Identive INVE Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $124.53M-3.2% | $128.61M+1.9% | $126.27M-2.4% | $129.34M-2.3% | $132.38M-2.4% | ||
| $3.21M-21.1% | $4.07M-7.6% | $4.4M+27.0% | $3.47M-4.3% | $3.62M-14.0% | ||
| $8.91M+20.1% | $7.42M+25.6% | $5.91M-3.7% | $6.13M-21.0% | $7.76M+3.8% | ||
| $138.92M-2.6% | $142.67M+0.4% | $142.13M-1.4% | $144.11M-3.1% | $148.71M-2.7% | ||
| $7.68M+4.9% | $7.32M-0.7% | $7.37M-2.1% | $7.53M-0.8% | $7.59M-1.4% | ||
| —— | —— | —— | —— | —— | ||
| $147.63M-2.4% | $151.34M+0.2% | $151.02M-1.9% | $153.88M-3.1% | $158.74M-2.8% | ||
| $6.5M+79.7% | $3.62M+48.6% | $2.44M+34.7% | $1.81M-33.0% | $2.7M-1.6% | ||
| $0-100% | $2.76M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $9.34M-0.5% | $9.39M+39.3% | $6.74M+1.5% | $6.64M-8.4% | $7.25M-8.9% | ||
| $10.48M-1.4% | $10.64M+44.5% | $7.36M-1.4% | $7.46M-9.4% | $8.24M-10.0% | ||
| $26K0.0% | $26K0.0% | $26K0.0% | $26K0.0% | $26K0.0% | ||
| -$361.5M-1.0% | -$358.05M-1.1% | -$354.33M-1.0% | -$350.88M-1.8% | -$344.84M-1.4% | ||
| $137.15M-2.5% | $140.7M-2.1% | $143.67M-1.9% | $146.42M-2.7% | $150.5M-2.3% | ||
| $147.63M-2.4% | $151.34M+0.2% | $151.02M-1.9% | $153.88M-3.1% | $158.74M-2.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Identive's total assets?
- Identive (INVE) holds $147.6M in total assets, down 7.0% year over year.
- How much debt does Identive have?
- Identive carries $730.0K in total debt against $137.2M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Identive have?
- Identive holds $124.5M in cash and equivalents.
- Can Identive cover its short-term obligations?
- Its current ratio is 14.87 — current assets exceed current liabilities.
- Where does Identive's balance sheet data come from?
- Every line is extracted from Identive's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
